A U.S. Food and Drug Administration panel has recommended allowing the diabetes drug Avandia to remain on the market with relaxed restrictions on its use, according to NBC News.
The story says Avandia was once the world’s top-selling diabetes drug. But in 2007, an analysis of other studies suggested that it raised the risk of heart attack by 43 percent. European regulators removed it from the market in 2010 and the ...
continue reading...
Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has pleaded guilty to drug safety violations. According to a story in the New York Times, the company will pay $500 million in fines over allegations that it sold subpar drugs.
Company officials also allegedly made false statements to the U.S. Food and Drug Administration about manufacturing practices at two factories in India.
Daiichi Sankyo has faced other allegations recently concerning its medications.
Two ...
continue reading...
Reuters reports on a recently approved intrauterine device from Bayer, which is the first new device of its type that the FDA has approved in 12 years.
According to the report, the new IUD is called Skyla. It’s a T-shaped polyethylene device that prevents pregnancy by releasing low doses of the hormone progestin.
Bayer manufactures another IUD available on the U.S. market called Mirena. But where Mirena is designed for use by ...
continue reading...
The prestigious medical journal BMJ has published a damning investigative article on a crop of new diabetes drugs called “incretin therapies,” which include Byetta and Januvia.
The article mentions a number of studies that have been published in recent years, indicating a potential link between these drugs and a potentially deadly inflammation of the pancreas called pancreatitis, as well as pancreatic cancer. Byetta has also been linked to thyroid cancer.
But the ...
continue reading...According to U.S. News and World Report, the Food and Drug Administration’s decision to reevaluate the diabetes drug Avandia is proving controversial, with some detractors accusing the agency of unnecessarily wasting taxpayer resources.
Avandia was once a top-selling medication for its manufacturer, GlaxoSmithKline. But a 2007 study concluded that it raised the risk of heart attack by more than 40 percent. As a result, the FDA imposed restrictions on Avandia in ...
continue reading...
According to British newspaper the Mansfield and Ashfield Chad, a 26-year-old man left disabled from birth because of a traumatic brain injury has successfully sued for damages.
Although the amount is undisclosed, the story says the equivalent of millions of dollars have been awarded in similar cases.
The man’s mother filed the lawsuit on his behalf. According to the story, he was deprived of oxygen during his birth at King’s Mill Hospital ...
continue reading...
